Have you ever left a conference and realized that you forgot to ask the question you came to get answered? Ever wonder what the FDA’s criteria may be when reviewing your PMA/510(k) submission? Join us at MDMA’s FDA Forum on March 14-15, 2019 in Palo Alto, CA to get your questions answered.
MDMA’s 2019 FDA Forum continues to grow as THE conference to engage with leading policy makers and experts. Be sure not to miss out hearing from FDA officials on how to get your technologies into the marketplace.
Confirmed FDA Speakers Include:
- William Maisel, Deputy Center Director for Science & Chief Scientist, CDRH, FDA
- Bakul Patel, Associate Director for Digital Health, Office of the Center Director, CDRH, FDA
- Marjorie Shulman, Chief of Premarket Notification (510(k)) Section, Office of Device Evaluation, CDRH, FDA
This is a RARE opportunity to share YOUR concerns and ask YOUR questions from some of the FDA’s top officials.
MDMA Members – $595
State Member – $795
Non-Members – $895
For more information and to register, CLICK HERE